Sex and Ethnic Disparities in Hepatitis B Evaluation and Treatment across the World

Rinaudo Veronica^*
*Correspondence: Rinaudo Veronica, Department of Pathology, Bucharest Institute of Oncology, 022328 Bucharest, Romania, Email:

Description

Research indicates that women with chronic HBV are less likely to receive treatment compared to men. Although women are more likely to be adequately evaluated for HBV, they are about 50% less likely to initiate treatment when it is indicated. This discrepancy is partly due to gender biases in healthcare and potential differences in the perception of treatment risks and benefits by healthcare providers and patients themselves. Ethnic disparities in HBV treatment are stark, especially among Asian minorities in Western countries. Studies show that Asian patients in the West are 40-50% less likely to receive adequate evaluation or initiate antiviral treatment compared to their counterparts in the East. This gap can be attributed to several factors, including language barriers, cultural differences, and socioeconomic challenges. In the United States, for example, the prevalence of HBV is highest among Asians compared to other ethnic groups, yet their access to treatment remains disproportionately low [1].

The barriers to adequate HBV treatment and evaluation are multifaceted. Socioeconomic factors, such as lack of insurance and lower income levels, play a significant role. Additionally, there are cultural barriers, including stigma associated with HBV, and a lack of culturally competent healthcare services. For instance, many Asian immigrants may not seek treatment due to fear of discrimination or because they are unaware of the availability and importance of treatment. The World Health Organization (WHO) has been actively working to address these disparities. Recent guidelines emphasize the need for simplified and expanded eligibility for HBV treatment to overcome existing barriers. Efforts include promoting universal infant HBV immunization and timely hepatitis B birth doses, which are crucial in preventing mother-to-child transmission, a significant source of HBV infections worldwide. To reduce these disparities, there is a need for targeted interventions [2].

Culturally tailored education programs to raise awareness about HBV and the importance of treatment among high-risk populations. Policies to improve access to healthcare services for underserved populations, including expanded insurance coverage and community health initiatives. Educating healthcare providers on cultural competencies and the importance of unbiased treatment to ensure that all patients receive the care they need. Addressing these disparities requires a concerted effort from global health organizations, governments, and local communities to ensure equitable access to HBV evaluation and treatment for all individuals, regardless of sex or ethnicity. Tailored education programs can raise awareness about HBV, its transmission routes, and the importance of timely evaluation and treatment, especially among high-risk populations such as women and ethnic minorities. These programs should be culturally sensitive to ensure effectiveness [3].

Policies aimed at improving access to healthcare services are vital. This includes expanding insurance coverage, particularly for underserved populations, and implementing community health initiatives that provide accessible and affordable care for all individuals, irrespective of their socioeconomic status or ethnicity. Healthcare providers need to be educated on cultural competencies to provide culturally sensitive care and address potential biases in evaluation and treatment. Training programs should emphasize the importance of unbiased treatment and ensure that healthcare professionals are equipped to provide equitable care to all patients [4]. Efforts to support universal infant HBV immunization and timely hepatitis B birth doses are critical in preventing mother-to-child transmission, which is a significant contributor to HBV infections worldwide. Promoting these initiatives can help reduce the burden of HBV in future generations. Engaging local communities in awareness campaigns and healthcare initiatives can foster trust and encourage individuals to seek evaluation and treatment for HBV. Community leaders and organizations can play a pivotal role in advocating for equitable access to healthcare services and addressing cultural stigmas associated with HBV [5].

Acknowledgement

None.

Conflict of Interest

None.

References

1. Lovy, Jan and Sarah E. Friend. "Intestinal coccidiosis of anadromous and landlocked alewives, Alosa pseudoharengus, caused by Goussia ameliae n. sp. and G. alosii n. sp.(Apicomplexa: Eimeriidae)." Int J Parasitol Parasites Wildl 4 (2015): 159-170.

Google Scholar, Crossref, Indexed at

2. Magnius, Lars, William S. Mason, John Taylor and Michael Kann, et al. "ICTV virus taxonomy profile: Hepadnaviridae." J Gen Virol 101 (2020): 571-572.

Google Scholar, Crossref, Indexed at

3. Dill, Jennifer A., Alvin C. Camus, John H. Leary and Francesca Di Giallonardo, et al. "Distinct viral lineages from fish and amphibians reveal the complex evolutionary history of hepadnaviruses." J Virol 90 (2016): 7920-7933.

Google Scholar, Crossref, Indexed at

4. Lauber, Chris, Stefan Seitz, Simone Mattei and Alexander Suh, et al. "Deciphering the origin and evolution of hepatitis B viruses by means of a family of non-enveloped fish viruses." Cell Host Microbe 22 (2017): 387-399.

Google Scholar, Crossref, Indexed at

5. Adams, Cynthia R., Vicki S. Blazer, Jim Sherry and Robert Scott Cornman, et al. "Phylogeographic genetic diversity in the white sucker hepatitis B virus across the Great Lakes region and Alberta, Canada." Viruses 13 (2021): 285.

Google Scholar, Crossref, Indexed at